IL131447A0 - Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms - Google Patents

Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms

Info

Publication number
IL131447A0
IL131447A0 IL13144798A IL13144798A IL131447A0 IL 131447 A0 IL131447 A0 IL 131447A0 IL 13144798 A IL13144798 A IL 13144798A IL 13144798 A IL13144798 A IL 13144798A IL 131447 A0 IL131447 A0 IL 131447A0
Authority
IL
Israel
Prior art keywords
treatment
neoplasms
chemotherapy
gene therapy
tumor suppressor
Prior art date
Application number
IL13144798A
Other languages
English (en)
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of IL131447A0 publication Critical patent/IL131447A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
IL13144798A 1997-02-18 1998-02-17 Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms IL131447A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US3806597P 1997-02-18 1997-02-18
US80168197A 1997-02-18 1997-02-18
US80128597A 1997-02-18 1997-02-18
US80175597A 1997-02-18 1997-02-18
US80176597A 1997-02-18 1997-02-18
US4783497P 1997-05-28 1997-05-28
PCT/US1998/003514 WO1998035554A2 (en) 1997-02-18 1998-02-17 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Publications (1)

Publication Number Publication Date
IL131447A0 true IL131447A0 (en) 2001-01-28

Family

ID=27556335

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13144798A IL131447A0 (en) 1997-02-18 1998-02-17 Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms
IL195605A IL195605A0 (en) 1997-02-18 2008-11-30 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL195605A IL195605A0 (en) 1997-02-18 2008-11-30 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Country Status (19)

Country Link
EP (1) EP0969720B1 (es)
JP (1) JP2001511815A (es)
KR (2) KR100620939B1 (es)
CN (1) CN1248731C (es)
AT (1) ATE361668T1 (es)
AU (1) AU737621B2 (es)
BR (1) BR9807418A (es)
CA (1) CA2282683A1 (es)
CZ (1) CZ298488B6 (es)
DE (1) DE69837754T2 (es)
ES (1) ES2287974T3 (es)
HK (1) HK1026579A1 (es)
HU (1) HUP0004326A3 (es)
IL (2) IL131447A0 (es)
NO (1) NO993943L (es)
NZ (1) NZ337283A (es)
PL (1) PL193767B1 (es)
SK (1) SK285969B6 (es)
WO (1) WO1998035554A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
CN1203632A (zh) 1995-07-17 1998-12-30 德克萨斯州立大学董事会 P16表达构建物及其在癌治疗中的应用
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
ATE550429T1 (de) 1996-11-20 2012-04-15 Crucell Holland Bv Adenovirus-zusammensetzungen erhältlich durch ein verbessertes produktions- und reinigungsverfahren
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
MY137303A (en) * 1997-12-22 2009-01-30 Schering Corp Methods for treating proliferative diseases
CA2325561A1 (en) * 1998-04-22 1999-10-28 Inex Pharmaceuticals Corporation Combination therapy using nucleic acids and conventional drugs
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
WO2000056351A2 (en) * 1999-03-19 2000-09-28 Schering Corporation Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7048920B2 (en) 2000-03-24 2006-05-23 Cell Genesys, Inc. Recombinant oncolytic adenovirus for human melanoma
US6911200B2 (en) 2000-03-24 2005-06-28 Cell Genesys, Inc. Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
EP2241887B1 (en) * 2000-11-27 2015-01-14 Minerva Biotechnologies Corporation Diagnostics, drug screening and treatment for cancer
EP1340498A1 (en) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Use of epothilones in the treatment of brain diseases associated with proliferative processes
US7364727B2 (en) 2002-07-22 2008-04-29 Cell Genesys, Inc. Metastatic colon cancer specific promoter and uses thereof
WO2005082396A2 (en) 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Use of mda-7 to inhibit infection by pathogenic organisms
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
JPWO2005061001A1 (ja) * 2003-12-24 2007-07-12 株式会社ロコモジェン 癌の抑制方法
JP2008518632A (ja) 2004-11-03 2008-06-05 イントロゲン セラピューティックス， インコーポレイテッド アデノウイルスベクターの製造および精製のための新規方法
EP3256494A4 (en) 2015-02-10 2018-12-05 Minerva Biotechnologies Corporation Humanized anti-muc1* antibodies
CN106692989A (zh) * 2017-03-07 2017-05-24 大连民族大学 一种药物脂质体/p53基因复合物及其制备方法和应用
CN109200295A (zh) * 2018-10-08 2019-01-15 蚌埠医学院 一种用于治疗卵巢癌的药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
ATE210653T1 (de) * 1993-10-15 2001-12-15 Schering Corp Tricyclische sulfonamide-derivate zur inhibierung der g-protein funktion und fur die bekandlung von proliferativen erkrantungen
WO1997023478A1 (en) * 1995-12-22 1997-07-03 Schering Corporation Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
HK1026579A1 (en) 2000-12-22
NO993943D0 (no) 1999-08-17
JP2001511815A (ja) 2001-08-14
CN1248731C (zh) 2006-04-05
EP0969720A2 (en) 2000-01-12
EP0969720B1 (en) 2007-05-09
SK112299A3 (en) 2000-12-11
DE69837754D1 (de) 2007-06-21
CZ298488B6 (cs) 2007-10-17
HUP0004326A2 (hu) 2001-02-28
NO993943L (no) 1999-10-15
IL195605A0 (en) 2011-08-01
KR100620939B1 (ko) 2006-09-06
PL193767B1 (pl) 2007-03-30
CZ293399A3 (cs) 2000-03-15
EP0969720A4 (en) 2004-05-12
CN1252689A (zh) 2000-05-10
DE69837754T2 (de) 2008-02-07
WO1998035554A2 (en) 1998-08-20
ES2287974T3 (es) 2007-12-16
SK285969B6 (sk) 2007-12-06
AU737621B2 (en) 2001-08-23
KR100688409B1 (ko) 2007-03-02
WO1998035554A3 (en) 1998-11-26
KR20000071185A (ko) 2000-11-25
HUP0004326A3 (en) 2003-07-28
PL335334A1 (en) 2000-04-25
KR20050113287A (ko) 2005-12-01
AU6438098A (en) 1998-09-08
NZ337283A (en) 2001-02-23
CA2282683A1 (en) 1998-08-20
ATE361668T1 (de) 2007-06-15
BR9807418A (pt) 2002-01-22

Similar Documents

Publication Publication Date Title
IL195605A0 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
EP1004022A4 (en) METHODS AND COMPOSITIONS FOR OVERCOMING RESISTANCE TO BIOLOGICAL THERAPY AND CHEMOTHERAPY
EP1167972A3 (en) Enzyme catalyzed therapeutic agents
TR199902053T2 (xx) Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE69837529D1 (de) Proteinmarker für lungenkrebs und deren verwendung
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
WO2000028090A3 (en) Diagnostic assay for cancer
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
MX9706109A (es) Moleculas de adn, preparacion y utilizacion en terapia genica.
AU7013401A (en) Methods for enhancing antibody-induced cell lysis and treating cancer
MY138257A (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
IL128872A0 (en) TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods
WO2003008578A3 (en) Reagents and methods for identifying gene targets for treating cancer
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
AU6249098A (en) Method of treating cancer using alkylglycerols in conjunction with chemotherapy
EP0950062A4 (en) PROTEIN MARKER FOR OESOPHAGUS CANCER
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2000056351A3 (en) Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
WO2000036420A3 (en) Differential expression in primary breast cancer
GB9723824D0 (en) Cytostatic agents
EP1240922A3 (en) Methods and compositions for overcoming resistance to biologic and chemotherapy
ATE308555T1 (de) Tumorsuppressormoleküle und nutzungsverfahren
UA25582C2 (uk) Засіб для лікування гематоцитопенічних реакцій теплокровних організмів
MX9802005A (es) Moleculas de adn circular con origen de replicacion condicional, su proceso de preparacion y su utilizacion en terapia genica.